Cadrenal Therapeutics, Inc. (CVKD)
8.49
+0.11
(+1.31%)
USD |
NASDAQ |
Feb 27, 16:00
8.56
+0.07
(+0.82%)
After-Hours: 20:00
Cadrenal Therapeutics Shareholders Equity (Quarterly) : 2.735M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -205.31M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -274.14M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.088M |
| Total Liabilities (Quarterly) | 1.353M |
| Current Ratio | 2.949 |
| Net Debt Paydown Yield | 0.01% |